Company: EDSA
Filing Date: 2025-03-11
Form Type: 424B3
Source: 0001171843-25-001403
Chunk: 23

Company: Edesa Biotech, Inc.
Filing Date: 2025-03-11
Form: 424B3
Chunk 23
---
 change in a previously filed early warning report also triggers the issuance and filing of a new press release and
early warning report. During the period commencing on the occurrence of an event in respect of which an early warning report is required
and terminating on the expiry of one business day from the date that the early warning report is filed, the offeror may not acquire or
offer to acquire beneficial ownership of any securities of the class in respect of which the early warning report was required to be filed
or any securities convertible into securities of that class. This requirement does not apply to an offeror that has beneficial ownership
of, or control or direction over, securities that comprise 20% or more of the outstanding securities of the class.

Related party transactions, issuer bids
and insider bids are subject to additional regulation that may differ depending on the particular jurisdiction of Canada in which it occurs.

#### Transfer Agent and Registrar
The transfer agent and registrar for
our common shares is Computershare Investor Services Inc. located at 510 Burrard St – 3rd Floor, Vancouver, BC V6C 3B9, and its
telephone number is 1-604-661-9400.

#### Listing on The Nasdaq Capital Market
Our common shares are listed on The Nasdaq Capital Market under the symbol “EDSA.”

| 17 |

### LEGAL MATTERS
The validity of the Shares and Conversion Shares offered hereby will be passed upon
for us by Fasken Martineau DuMoulin, LLP.

| 18 |

### EXPERTS
The consolidated financial statements
incorporated into this prospectus by reference to our Annual Report on Form 10-K for the financial years ended September 30, 2024 and
September 30, 2023, have been so incorporated in reliance on the report of MNP LLP, independent auditors, given on the authority of said
firm as experts in auditing and accounting.

| 19 |

### WHERE YOU CAN FIND MORE INFORMATION
We are subject to the informational
requirements of the Exchange Act, and in accordance therewith file annual, quarterly and current reports, proxy statements and other information
with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants
that file electronically with the SEC. The address of the SEC’s website is www.sec.gov.

We make available free of charge on
or through our website at www.edesabiotech.com, our Annual Reports on Form 10-K